VALBENAZINE

N/A

Manufactured by Neurocrine Biosciences, Inc.

34,810 FDA adverse event reports analyzed

Last updated: 2026-04-14

About VALBENAZINE

VALBENAZINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Neurocrine Biosciences, Inc.. The most commonly reported adverse reactions for VALBENAZINE include DRUG INEFFECTIVE, SOMNOLENCE, FATIGUE, TREMOR, TARDIVE DYSKINESIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for VALBENAZINE.

Top Adverse Reactions

DRUG INEFFECTIVE2,719 reports
SOMNOLENCE2,412 reports
FATIGUE1,646 reports
TREMOR1,539 reports
TARDIVE DYSKINESIA1,471 reports
FALL1,104 reports
DIZZINESS930 reports
DEATH912 reports
DROOLING881 reports
THERAPEUTIC PRODUCT EFFECT DECREASED858 reports
DYSKINESIA826 reports
OFF LABEL USE669 reports
ANXIETY654 reports
HOSPITALISATION650 reports
NAUSEA615 reports
PARKINSONISM598 reports
ADVERSE DRUG REACTION558 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE554 reports
INSOMNIA551 reports
BALANCE DISORDER538 reports
DEPRESSION474 reports
GAIT DISTURBANCE456 reports
FEELING ABNORMAL454 reports
HEADACHE445 reports
RESTLESSNESS439 reports
SEDATION420 reports
ASTHENIA390 reports
RASH353 reports
URTICARIA349 reports
VOMITING342 reports
DYSPNOEA317 reports
MALAISE286 reports
DIARRHOEA282 reports
CONFUSIONAL STATE277 reports
CONSTIPATION259 reports
SUICIDAL IDEATION240 reports
LETHARGY235 reports
AKATHISIA230 reports
WEIGHT INCREASED217 reports
DRY MOUTH216 reports
URINARY TRACT INFECTION215 reports
AGITATION199 reports
DRUG INTOLERANCE192 reports
DYSPHAGIA183 reports
DRUG EFFECT DECREASED178 reports
VISION BLURRED178 reports
MUSCULAR WEAKNESS176 reports
COVID 19174 reports
ABDOMINAL DISCOMFORT166 reports
PNEUMONIA162 reports
DEPRESSED MOOD160 reports
MUSCULOSKELETAL STIFFNESS160 reports
WEIGHT DECREASED160 reports
MEMORY IMPAIRMENT155 reports
HYPERSENSITIVITY153 reports
DYSARTHRIA146 reports
SPEECH DISORDER146 reports
PAIN144 reports
DRUG INTERACTION143 reports
DECREASED APPETITE141 reports
DRUG EFFECT INCOMPLETE141 reports
SALIVARY HYPERSECRETION140 reports
MUSCLE SPASMS133 reports
PRURITUS131 reports
ARTHRALGIA129 reports
SEIZURE128 reports
DISTURBANCE IN ATTENTION121 reports
PAIN IN EXTREMITY117 reports
PALPITATIONS116 reports
NERVOUSNESS114 reports
PRESCRIBED OVERDOSE113 reports
HALLUCINATION112 reports
CHEST PAIN111 reports
NIGHTMARE111 reports
RESTLESS LEGS SYNDROME111 reports
AGGRESSION106 reports
GAIT INABILITY106 reports
IRRITABILITY103 reports
HYPERHIDROSIS102 reports
MUSCLE TWITCHING101 reports
PSYCHOTIC DISORDER101 reports
ABNORMAL BEHAVIOUR100 reports
LOSS OF CONSCIOUSNESS100 reports
TREATMENT NONCOMPLIANCE99 reports
PRODUCT DOSE OMISSION ISSUE98 reports
BRADYKINESIA96 reports
DRUG HYPERSENSITIVITY91 reports
DEHYDRATION89 reports
ADVERSE EVENT88 reports
BLOOD PRESSURE INCREASED88 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES87 reports
PARKINSON^S DISEASE87 reports
URINARY RETENTION86 reports
MIGRAINE85 reports
DYSTONIA81 reports
PANIC ATTACK81 reports
ABDOMINAL PAIN UPPER78 reports
BACK PAIN78 reports
CEREBROVASCULAR ACCIDENT78 reports
ABNORMAL DREAMS76 reports

Report Outcomes

Out of 24,300 classified reports for VALBENAZINE:

Serious 23.8%Non-Serious 76.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female10,449 (67.1%)
Male5,128 (32.9%)
Unknown4 (0.0%)

Reports by Age

Age 64334 reports
Age 60320 reports
Age 63306 reports
Age 65301 reports
Age 62282 reports
Age 70276 reports
Age 67274 reports
Age 66273 reports
Age 68272 reports
Age 59267 reports
Age 69257 reports
Age 61256 reports
Age 57243 reports
Age 55234 reports
Age 58232 reports
Age 72230 reports
Age 56227 reports
Age 71227 reports
Age 53193 reports
Age 54193 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with VALBENAZINE?

This profile reflects 34,810 FDA FAERS reports that mention VALBENAZINE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for VALBENAZINE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, SOMNOLENCE, FATIGUE, TREMOR, TARDIVE DYSKINESIA, FALL. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures VALBENAZINE?

Labeling and FAERS entries often list Neurocrine Biosciences, Inc. in connection with VALBENAZINE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.